Epidermal omega-O-acylceramides (ω-O-acylCers) are essential components of a competent skin barrier. These unusual sphingolipids with ultralong N-acyl chains contain linoleic acid esterified to the terminal hydroxyl of the N-acyl, the formation of which requires the transacylase activity of patatin-like phospholipase domain containing 1 (PNPLA1). In ichthyosis with dysfunctional PNPLA1, ω-O-acylCer levels are significantly decreased, and ω-hydroxylated Cers (ω-OHCers) accumulate. Here, we explore the role of the linoleate moiety in ω-O-acylCers in the assembly of the skin lipid barrier. Ultrastructural studies of skin samples from neonatal Pnpla1+/+ and Pnpla1-/- mice showed that the linoleate moiety in ω-O-acylCers is essential for lamellar pairing in lamellar bodies, as well as for stratum corneum lipid assembly into the long periodicity lamellar phase. To further study the molecular details of ω-O-acylCer deficiency on skin barrier lipid assembly, we built in vitro lipid models composed of major stratum corneum lipid subclasses containing either ω-O-acylCer (healthy skin model), ω-OHCer (Pnpla1-/- model), or combination of the two. X-ray diffraction, infrared spectroscopy, and permeability studies indicated that ω-OHCers could not substitute for ω-O-acylCers, although in favorable conditions, they form a medium lamellar phase with a 10.8 nm-repeat distance and permeability barrier properties similar to long periodicity lamellar phase. In the absence of ω-O-acylCers, skin lipids were prone to separation into two phases with diminished barrier properties. The models combining ω-OHCers with ω-O-acylCers indicated that accumulation of ω-OHCers does not prevent ω-O-acylCer-driven lamellar stacking. These data suggest that ω-O-acylCer supplementation may be a viable therapeutic option in patients with PNPLA1 deficiency.

Charles University Faculty of Pharmacy in Hradec Králové Hradec Králové Czech Republic

Department of Dermatology Vanderbilt University Medical Center Nashville TN USA

Institute of Molecular Biosciences University of Graz Graz Austria

See more in PubMed

Madison K.C. Barrier function of the skin: "La Raison d'Etre" of the epidermis. J. Invest. Dermatol. 2003;121:231–241. PubMed

Elias P.M. Epidermal barrier function: intercellular lamellar lipid structures, origin, composition and metabolism. J. Control Release. 1991;15:199–208.

Masukawa Y., Narita H., Sato H., Naoe A., Kondo N., Sugai Y., et al. Comprehensive quantification of ceramide species in human stratum corneum. J. Lipid Res. 2009;50:1708–1719. PubMed PMC

Motta S., Monti M., Sesana S., Caputo R., Carelli S., Ghidoni R. Ceramide composition of the psoriatic scale. Biochim. Biophys. Acta. 1993;1182:147–151. PubMed

van Smeden J., Boiten W.A., Hankemeier T., Rissmann R., Bouwstra J.A., Vreeken R.J. Combined LC/MS-platform for analysis of all major stratum corneum lipids, and the profiling of skin substitutes. BBA-Mol. Cell Biol. L. 2014;1841:70–79. PubMed

t'Kindt R., Jorge L., Dumont E., Couturon P., David F., Sandra P., et al. Profiling and characterizing skin ceramides using reversed-phase liquid chromatography-quadrupole time-of-flight mass spectrometry. Anal. Chem. 2012;84:403–411. PubMed

Wertz P.W., Downing D.T. Ceramides of pig epidermis: structure determination. J. Lipid Res. 1983;24:759–765. PubMed

Bowser P.A., Nugteren D., White R.J., Houtsmuller U., Prottey C. Identification, isolation and characterization of epidermal lipids containing linoleic acid. Biochim. Biophys. Acta. 1985;834:419–428. PubMed

Kihara A. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides. Prog. Lipid Res. 2016;63:50–69. PubMed

Ishikawa J., Narita H., Kondo N., Hotta M., Takagi Y., Masukawa Y., et al. Changes in the ceramide profile of Atopic Dermatitis patients. J. Invest. Dermatol. 2010;130:2511–2514. PubMed

Janssens M., van Smeden J., Gooris G.S., Bras W., Portale G., Caspers P.J., et al. Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema. J. Invest. Dermatol. 2011;131:2136–2138. PubMed

Bouwstra J.A., Cheng K., Gooris G., Weerheim A., Ponec M. The role of ceramides 1 and 2 in the stratum corneum lipid organisation. Bba-lipid. Lipid Met. 1996;1300:177–186. PubMed

Bouwstra J.A., Gooris G.S., Dubbelaar F.E.R., Weerheim A.M., Ijzerman A.P., Ponec M. Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J. Lipid Res. 1998;39:186–196. PubMed

Opálka L., Kováčik A., Pullmannová P., Maixner J., Vávrová K. Effects of omega-O-acylceramide structures and concentrations in healthy and diseased skin barrier lipid membrane models. J. Lipid Res. 2020;61:219–228. PubMed PMC

Pham Q.D., Mojumdar E.H., Gooris G.S., Bouwstra J.A., Sparr E., Topgaard D. Solid and fluid segments within the same molecule of stratum corneum ceramide lipid. Q. Rev. Biophys. 2018;51 PubMed

Ongpipattanakul B., Francoeur M.L., Potts R.O. Polymorphism in stratum corneum lipids. BBA-Biomem. 1994;1190:115–122. PubMed

Takeichi T., Hirabayashi T., Miyasaka Y., Kawamoto A., Okuno Y., Taguchi S., et al. SDR9C7 catalyzes critical dehydrogenation of acylceramides for skin barrier formation. J. Clin. Invest. 2020;130:890–903. PubMed PMC

Wertz P.W., Madison K.C., Downing D.T. Covalently bound lipids of human stratum corneum. J. Invest. Dermatol. 1989;92:109–111. PubMed

Akiyama M. Corneocyte lipid envelope (CLE), the key structure for skin barrier function and ichthyosis pathogenesis. J. Dermatol. Sci. 2017;88:3–9. PubMed

Crumrine D., Khnykin D., Krieg P., Man M.-Q., Celli A., Mauro T.M., et al. Mutations in recessive congenital ichthyoses illuminate the origin and functions of the corneocyte lipid envelope. J. Invest. Dermatol. 2019;139:760–768. PubMed PMC

Janssens M., van Smeden J., Gooris G.S., Bras W., Portale G., Caspers P.J., et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J. Lipid Res. 2012;53:2755–2766. PubMed PMC

Jennemann R., Rabionet M., Gorgas K., Epstein S., Dalpke A., Rothermel U., et al. Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum. Mol. Genet. 2012;21:586–608. PubMed

van Smeden J., Janssens M., Gooris G.S., Bouwstra J.A. The important role of stratum corneum lipids for the cutaneous barrier function. BBA-Mol. Cell Biol. L. 2014;1841:295–313. PubMed

Macheleidt O., Kaiser H.W., Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J. Invest. Dermatol. 2002;119:166–173. PubMed

Jungersted J., Scheer H., Mempel M., Baurecht H., Cifuentes L., Høgh J., et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy. 2010;65:911–918. PubMed

Paige D., Morse-Fisher N., Harper J. Quantification of stratum corneum ceramides and lipid envelope ceramides in the hereditary ichthyoses. Br. J. Dermatol. 1994;131:23–27. PubMed

Oji V., Tadini G., Akiyama M., Bardon C.B., Bodemer C., Bourrat E., et al. Revised nomenclature and classification of inherited ichthyoses: results of the first ichthyosis consensus conference in soreze 2009. J. Am. Acad. Dermatol. 2010;63:607–641. PubMed

Takeichi T., Akiyama M. Inherited ichthyosis: non-syndromic forms. J. Dermatol. 2016;43:242–251. PubMed

Ohno Y., Kamiyama N., Nakamichi S., Kihara A. PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide. Nat. Commun. 2017;8:14610. PubMed PMC

Pichery M., Huchenq A., Sandhoff R., Severino-Freire M., Zaafouri S., Opalka L., et al. PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega-O-acylceramide synthesis and skin permeability barrier. Hum. Mol. Genet. 2017;26:1787–1800. PubMed

Grond S., Eichmann T.O., Dubrac S., Kolb D., Schmuth M., Fischer J., et al. PNPLA1 deficiency in mice and humans leads to a defect in the synthesis of omega-O-acylceramides. J. J. Invest. Dermatol. 2017;137:394–402. PubMed PMC

Hirabayashi T., Anjo T., Kaneko A., Senoo Y., Shibata A., Takama H., et al. PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis. Nat. Commun. 2017;8:1–13. PubMed PMC

Grall A., Guaguère E., Planchais S., Grond S., Bourrat E., Hausser I., et al. PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans. Nat. Genet. 2012;44:140. PubMed

Opálka L., Kováčik A., Sochorová M., Roh J., Kuneš J., Lenčo J., et al. Scalable synthesis of human ultralong chain ceramides. Org. Lett. 2015;17:5456–5459. PubMed

Kováčik A., Vogel A., Adler J., Pullmannová P., Vávrová K., Huster D. Probing the role of ceramide hydroxylation in skin barrier lipid models by 2 H solid-state NMR spectroscopy and X-ray powder diffraction. BBA-Biomem. 2018;1860:1162–1170. PubMed

Meyer J.M., Crumrine D., Schneider H., Dick A., Schmuth M., Gruber R., et al. Unbound corneocyte lipid envelopes in 12R-lipoxygenase deficiency support a specific role in lipid-protein cross-linking. Am. J. Pathol. 2021;191:921–929. PubMed PMC

Groen D., Gooris G.S., Bouwstra J.A. Model membranes prepared with ceramide EOS, cholesterol and free fatty acids form a unique lamellar phase. Langmuir. 2010;26:4168–4175. PubMed

Wertz P.W., Schwartzendruber D.C., Madison K.C., Downing D.T. Composition and morphology of epidermal cyst lipids. J. Invest. Dermatol. 1987;89:419–425. PubMed

Školová B., Janůšová B., Zbytovská J., Gooris G., Bouwstra J., Slepička P., et al. Ceramides in the skin lipid membranes: length matters. Langmuir. 2013;29:15624–15633. PubMed

Pullmannová P., Staňková K., Pospíšilová M., Školová B., Zbytovská J., Vávrová K. Effects of sphingomyelin/ceramide ratio on the permeability and microstructure of model stratum corneum lipid membranes. BBA-Biomem. 2014;1838:2115–2126. PubMed

Pullmannová P., Pavlíková L., Kováčik A., Sochorová M., Školová B., Slepička P., et al. Permeability and microstructure of model stratum corneum lipid membranes containing ceramides with long (C16) and very long (C24) acyl chains. Biophys. Chem. 2017;224:20–31. PubMed

Kovacik A., Pullmannová P., Maixner J., Vavrova K. Effects of ceramide and dihydroceramide stereochemistry at C-3 on the phase behavior and permeability of skin lipid membranes. Langmuir. 2018;34:521–529. PubMed

Opálka L., Kováčik A., Maixner J., Vávrová K. Omega-O-acylceramides in skin lipid membranes: effects of concentration, sphingoid base, and model complexity on microstructure and permeability. Langmuir. 2016;32:12894–12904. PubMed

Hou S.Y.E., Mitra A.K., White S.H., Menon G.K., Ghadially R., Elias P.M. Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction. J. Invest. Dermatol. 1991;96:215–223. PubMed

Pullmannova P., Ermakova E., Kovacik A., Opalka L., Maixner J., Zbytovska J., et al. long and very long lamellar phases in model Stratum Corneum lipid membranes. J. Lipid Res. 2019;60:963–971. PubMed PMC

de Jager M., Gooris G., Ponec M., Bouwstra J. Acylceramide head group architecture affects lipid organization in synthetic ceramide mixtures. J. Invest. Dermatol. 2004;123:911–916. PubMed

Damien F., Boncheva M. The extent of orthorhombic lipid phases in the stratum corneum determines the barrier efficiency of human skin in vivo. J. Invest. Dermatol. 2010;130:611–614. PubMed

Mitragotri S. Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J. Control Release. 2003;86:69–92. PubMed

Yoshiike T., Aikawa Y., Sindhvananda J., Suto H., Nishimura K., Kawamoto T., et al. Skin barrier defect in atopic dermatitis: increased permeability of the stratum corneum using dimethyl sulfoxide and theophylline. J. Dermatol. Sci. 1993;5:92–96. PubMed

Boncheva M. The physical chemistry of the stratum corneum lipids. Int. J. Cosmet. Sci. 2014;36:505–515. PubMed

Engberg O., Kováčik A., Pullmannová P., Juhaščik M., Opálka L., Huster D., et al. The sphingosine and acyl chains of ceramide [NS] show very different structure and dynamics that challenge our understanding of the skin barrier. Angew. Chem. Int. Ed. 2020;59:17383–17387. PubMed PMC

Iwai I., Han H., den Hollander L., Svensson S., Öfverstedt L.-G., Anwar J., et al. The human skin barrier is organized as stacked bilayers of fully extended ceramides with cholesterol molecules associated with the ceramide sphingoid moiety. J. Invest. Dermatol. 2012;132:2215–2225. PubMed

Školová B., Hudská K., Pullmannová P., Kováčik A., Palát K., Roh J., et al. Different phase behavior and packing of ceramides with long (C16) and very long (C24) acyls in model membranes: infrared spectroscopy using deuterated lipids. J. Phys. Chem. B. 2014;118:10460–10470. PubMed

Kováčik A., Opálka L., Šilarová M., Roh J., Vávrová K. Synthesis of 6-hydroxyceramide using ruthenium-catalyzed hydrosilylation–protodesilylation. Unexpected formation of a long periodicity lamellar phase in skin lipid membranes. RSC Adv. 2016;6:73343–73350.

Bouwstra J.A., Gooris G.S., Dubbelaar F.E., Ponec M. Phase behavior of stratum corneum lipid mixtures based on human ceramides: the role of natural and synthetic ceramide 1. J. Invest. Dermatol. 2002;118:606–617. PubMed

Bouwstra J., Gooris G., Salomons-de Vries M., Van der Spek J., Bras W. Structure of human stratum corneum as a function of temperature and hydration: a wide-angle X-ray diffraction study. Int. J. Pharm. 1992;84:205–216.

Sagrafena I., Paraskevopoulos G., Pullmannová P., Opálka L., Nováčková A., Lourantou O., et al. Assembly of human stratum corneum lipids in vitro: fluidity matters. J. Invest. Dermatol. 2022 doi: 10.1016/j.jid.2021.12.008. PubMed DOI

Mauldin E.A., Crumrine D., Casal M.L., Jeong S., Opálka L., Vavrova K., et al. Cellular and metabolic basis for the ichthyotic phenotype in NIPAL4 (Ichthyin)–deficient canines. Am. J. Pathol. 2018;188:1419–1429. PubMed PMC

Lysosphingolipids in ceramide-deficient skin lipid models

The intriguing molecular dynamics of Cer[EOS] in rigid skin barrier lipid layers requires improvement of the model